• 8 February 2019

    Cognoa devices for autism obtain FDA breakthrough status

    Cognoa, a digital devices maker, has obtained the US Food and Drug Administration (FDA) breakthrough device designation for its diagnostic and therapeutic devices intended for autism spectrum disorder (ASD).

  • 29 January 2019

    Microdrop launches two direct-to-consumer tests

    Life sciences and diagnostics company SQI Diagnostics has announced that its partner company Microdrop has launched two new direct-to-consumer tests within the imaware family of at-home tests.

Go Top